Carmel Stock

Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis

Carmel Stock, Hiroe Sato, Carmen Fonseca et al. · Thorax · 2013 · 237 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial

Dina Visca, Letizia Mori, Vicky Tsipouri et al. · The Lancet Respiratory Medicine · 2018 · 228 citations · Full text

Medicine, Internal Medicine, Respiratory Therapy +12

Host–Microbial Interactions in Idiopathic Pulmonary Fibrosis

Philip L. Molyneaux, Saffron A.G. Willis‐Owen, Michael J. Cox et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 221 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17

A Polymorphism in the<i>CTGF</i>Promoter Region Associated with Systemic Sclerosis

Carmen Fonseca, Gisela Lindahl, Markella Ponticos et al. · New England Journal of Medicine · 2007 · 201 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease

Gisela Lindahl, Carmel Stock, Shiwen Xu et al. · Respiratory Research · 2013 · 102 citations · Full text

Life Sciences, Genetics, Molecular Biology +16